MCK McKesson Corporation
Company Analysis
Latest News
🟢 McKesson is trading 4.48% up in pre-market with no clear catalyst identified
McKesson is trading 4.48% up at $1,057.65, with no clear company-specific catalyst identified for the October 23 pre-market move. - Latest company-specific...
🟢 McKesson is trading 5% up in pre-market with no clear company catalyst
McKesson is trading at $1,065.09, up +4.88%, in pre-market on October 22; no clear fresh company announcement explains the rise. - McKesson’s announced...
🔴 McKesson is trading 5% down in pre-market
McKesson is trading 4.96% lower at $960.34 in pre-market on October 20, with no confirmed overnight announcement or clearly established catalyst directly...
🔴 McKesson is trading 10% down in after-hours trading; no confirmed catalyst identified
McKesson is trading at $898.82, down 10.04% in after-hours trading, with no confirmed catalyst identified. - McKesson closed at $999.11 on October 15, after...
McKesson to Acquire 49% Stake in Option Care Health in $5.8B Buyout Deal
McKesson Corporation, in partnership with private equity firm Clayton, Dubilier & Rice (CD&R), announced a definitive agreement to acquire Option Care Health,...
McKesson and CD&R to Acquire Option Care Health in $5.8 Billion Deal
Drug distributor McKesson is partnering with private equity firm Clayton, Dubilier & Rice (CD&R) to acquire Option Care Health, a leading provider of home and...
McKesson Nears $5B Option Care Health Deal With PE Firm
McKesson Corp. and private equity firm Clayton, Dubilier & Rice are in advanced negotiations to acquire Option Care Health. The deal is valued at more than $5...
McKesson Extends CVS Deal Through 2032, Shares Jump More Than 5%
McKesson Corporation extended its pharmaceutical distribution agreement with CVS Health through June 2032. The agreement covers CVS’s mail-order, specialty and...
McKesson Agrees in Principle to Extend CVS Drug Distribution Through 2032
McKesson Corporation has reached an agreement in principle to extend its pharmaceutical distribution partnership with CVS Health through June 2032. Under the...
🟢 McKesson is trading 4.4% up today — no clear company-specific catalyst identified
McKesson is trading 4.4% higher at $891.72, with available evidence not establishing a direct cause. - The most relevant company news is its fiscal 2027...
🟢 McKesson is trading 5.6% up in after-hours trading — move remains unexplained
McKesson is trading at $923.83, up 5.63%, with no verified company-specific catalyst identified for September 18, 2026. - Recent coverage highlighted raised...
🟢 McKesson is trading 5% up today in after-hours trading as major U.S. indexes advance
McKesson is trading at $924.39, up +4.89% after the September 11, 2026 close, amid broad risk-on market sentiment. - No clear September 11 company-specific...
🟢 McKesson is trading 5% up in pre-market despite disclosed cybersecurity incident
McKesson is trading at $927.60, up +4.89%, with no verified news catalyst identified for the pre-market gain. - McKesson is rising despite broad markets...
McKesson Discloses Cybersecurity Incident Affecting Its Information Systems
McKesson Corporation disclosed that on August 25, 2026, it discovered a cybersecurity incident that is impacting its information systems. The company has...
🔴 McKesson is trading 5% down in pre-market as investors seek acquisition synergy clarity
McKesson is trading at $857.38 (-5.27%) as investors seek greater clarity on synergies from its previously announced acquisition. - The $2.25 billion...
McKesson Buys Precision Medicine Group for $2.25B, Expanding Oncology Reach
McKesson Corporation signed a definitive agreement to acquire Precision Medicine Group for approximately $2.25 billion. The deal adds clinical research and...
Stephen Mandel's Lone Pine Capital Reduces Stake in McKesson by 85%
In a recent 13F filing with the SEC, Stephen Mandel's hedge fund, Lone Pine Capital, reported a significant reduction in its position in McKesson Corp (MCK)....
Farallon Capital Management exits its $202.75M stake in McKesson Corp
In a recent SEC 13F filing, Farallon Capital Management disclosed the complete liquidation of its position in McKesson Corp (MCK) during the second quarter of...
🔴 McKesson is trading 4% down today amid Medical-Surgical adjusted operating profit falling 20%
McKesson is trading at $842.00, down 4.02%, after investors digested its August 5 earnings release, with concern focused on Medical-Surgical weakness. -...
McKesson's first quarter revenue beats estimates at $105.4B, prompting a raise in FY27 EPS guidance.
McKesson reported first quarter fiscal 2027 revenue of $105.4 billion, an 8% year-over-year increase, and adjusted earnings of $9.93 per share, up 20%. The...